Recida Therapeutics
VerifiedRecida Therapeutics is a Biotechnology company.
Launch date
Market cap
-
Net debt
-
Enterprise valuation
$34—51m (Dealroom.co estimates Feb 2019.)
Menlo Park California (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $0.0 | round | |
$8.5m | Series A | ||
| Total Funding | 000k | ||
Related Content
Recent News about Recida Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.